Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Effect of Pinus massoniana Lamb. bark extract on lytic cycle of Epstein-Barr virus.

Xu S, Zhang S, Wang X, Gao Y, Qin X, Wu K.

Indian J Exp Biol. 2012 Oct;50(10):708-13.

PMID:
23214264
2.

Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone.

Tung CP, Chang FR, Wu YC, Chuang DW, Hunyadi A, Liu ST.

J Gen Virol. 2011 Aug;92(Pt 8):1760-8. doi: 10.1099/vir.0.031609-0. Epub 2011 Apr 13.

PMID:
21490247
3.

Inhibition of the epstein-barr virus lytic cycle by andrographolide.

Lin TP, Chen SY, Duh PD, Chang LK, Liu YN.

Biol Pharm Bull. 2008 Nov;31(11):2018-23.

4.
5.

Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle.

Yiu CY, Chen SY, Chang LK, Chiu YF, Lin TP.

Molecules. 2010 Oct 14;15(10):7115-24. doi: 10.3390/molecules15107115.

6.

The effect of Astragalus polysaccharide on the Epstein-Barr virus lytic cycle.

Guo Q, Sun X, Zhang Z, Zhang L, Yao G, Li F, Yang X, Song L, Jiang G.

Acta Virol. 2014;58(1):76-80.

PMID:
24717032
7.

Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.

Wu CC, Chuang HY, Lin CY, Chen YJ, Tsai WH, Fang CY, Huang SY, Chuang FY, Lin SF, Chang Y, Chen JY.

Mol Carcinog. 2013 Dec;52(12):946-58. doi: 10.1002/mc.21926. Epub 2012 May 29.

PMID:
22641235
8.

Lytic cycle switches of oncogenic human gammaherpesviruses.

Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L.

Adv Cancer Res. 2007;97:81-109. Review.

PMID:
17419942
9.

Inhibition of the Epstein-Barr virus lytic cycle by moronic acid.

Chang FR, Hsieh YC, Chang YF, Lee KH, Wu YC, Chang LK.

Antiviral Res. 2010 Mar;85(3):490-5. doi: 10.1016/j.antiviral.2009.12.002. Epub 2009 Dec 5.

PMID:
19969023
10.

Inhibition of Epstein-Barr virus lytic cycle by an ethyl acetate subfraction separated from Polygonum cuspidatum root and its major component, emodin.

Yiu CY, Chen SY, Yang TH, Chang CJ, Yeh DB, Chen YJ, Lin TP.

Molecules. 2014 Jan 20;19(1):1258-72. doi: 10.3390/molecules19011258.

11.

Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate.

Chang LK, Wei TT, Chiu YF, Tung CP, Chuang JY, Hung SK, Li C, Liu ST.

Biochem Biophys Res Commun. 2003 Feb 21;301(4):1062-8.

PMID:
12589821
12.

Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.

Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL, Kenney SC.

Cancer Res. 1999 Apr 1;59(7):1485-91.

13.

Antitumor effects of Pinus massoniana bark extract in murine sarcoma S180 both in vitro and in vivo.

Zhang JH, Feng DR, Ma HL, Liu B, Wang HB, Xie H, Li RD, Wang JF.

Am J Chin Med. 2012;40(4):861-75. doi: 10.1142/S0192415X12500644.

PMID:
22809037
14.
15.

Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.

Wu CC, Fang CY, Hsu HY, Chen YJ, Chou SP, Huang SY, Cheng YJ, Lin SF, Chang Y, Tsai CH, Chen JY.

Antiviral Res. 2016 Aug;132:99-110. doi: 10.1016/j.antiviral.2016.05.007. Epub 2016 May 13.

PMID:
27185626
16.

Effects of Pinus massoniana bark extract on the adhesion and migration capabilities of HeLa cells.

Wu DC, Li S, Yang DQ, Cui YY.

Fitoterapia. 2011 Dec;82(8):1202-5. doi: 10.1016/j.fitote.2011.08.008. Epub 2011 Aug 23.

PMID:
21888955
17.

Potential biomedical properties of Pinus massoniana bark extract.

Cui Y, Xie H, Wang J.

Phytother Res. 2005 Jan;19(1):34-8.

PMID:
15798999
18.

Interplay between PKCĪ“ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.

Tsai PF, Lin SJ, Weng PL, Tsai SC, Lin JH, Chou YC, Tsai CH.

J Virol. 2011 Mar;85(5):2373-85. doi: 10.1128/JVI.01602-10. Epub 2010 Dec 15.

19.

Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle.

Guo Q, Qian L, Guo L, Shi M, Chen C, Lv X, Yu M, Hu M, Jiang G, Guo N.

Mol Immunol. 2010 May;47(9):1783-92. doi: 10.1016/j.molimm.2010.02.017. Epub 2010 Mar 24.

PMID:
20338640
20.

Immune activation suppresses initiation of lytic Epstein-Barr virus infection.

Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D.

Cell Microbiol. 2007 Aug;9(8):2055-69. Epub 2007 Apr 5.

PMID:
17419714

Supplemental Content

Support Center